A rapid high-performance liquid chromatographic method for the measurement of midazolam plasma concentrations during long-term infusion in ICU patients

Therapeutic Drug Monitoring

Volumn 19, Issue 3, 1997, Pages 352-357

  Van Brandt, Nicolas ^a   Hantson, Philippe ^a   Mahieu, Paul ^a   Verbeeck, Roger K ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

High performance liquid chromatography; ICU patients; Midazolam

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; FLURAZEPAM; MIDAZOLAM; SODIUM HYDROXIDE; TOLUENE;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; PRIORITY JOURNAL;

ANESTHETICS, INTRAVENOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRITICAL CARE; HUMANS; MIDAZOLAM;

EID: 0031466109     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199706000-00017     Document Type: Article

References (18)

1. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam - a review of its pharmacological properties and therapeutic use. Drugs 1984;28:519-543.
2. Amrein R, Hetzel W. Pharmacology of drugs frequently used in ICUs: midazolam and flumezanil. Intens Care Med 1991;17: S1-S10.
3. Pohlman AS, Simpson KP, Hall JB. Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med 1994;22:1241-1247.
4. Smith MT, Eadie MJ, O'Rourke BT. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 1981;19:271-278.
5. Heizmann P, Eckert M, Ziegler WH. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmac 1983;16: 43S-49S.
6. Thummel KE, O'Shea D, Paine MF, Shen DD, Kunze KL, Perkins JD, Wilkinson GR. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 1996;59:491-502.
7. Pentikainen PJ, Valisalmi L, Himberg JJ, Crevoisier C. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. J Clin Pharmacol 1989:29:272-277.
8. Patel IH, Soni PP, Fukuda EK, Smith DF, Leier CV, Boudoulas H. The pharmacokinetics of midazolam in patients with chronic heart failure. Br J Clin Pharmacol 1990;29:565-569.
9. Thummel KE, Shen DD, Podoll TD et al. Use of midazolam as a human cytochrome P450 3A probe; I: in vitro-in vivo correlations in liver transplant patients. J Pharmacol Exp Ther 1994:271:549-556.
10. Oldenhof H, de Jong M, Steenhoek A, Janknegt R. Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? Clin Pharmacol Ther 1988;43:263-269.
11. Shafer A, Doze VA, White PF. Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med 1990; 18:1039-1041.
12. Puglisi CV, PaoJ, Ferrara FJ, de Silva JAF. Determination of midazolam (Versed) and its metabolites in plasma by high-performance liquid chromatography. J Chromatogr 1985;344:199-209.
13. Ha RH, Rentsch KM, Kneer J, Vonderschmitt DJ. Determination of midazolam and its α-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography. Ther Drug Monit 1993;15:338-343.
14. Cyracuse CD, Kuhnert BR, Kaine CJ. Measurement of midazolam and alpha-hydroxymidazolam by gas chromatography with electron-capture detection. J Chromatogr 1986;380:145-150.
15. de Kroon IFI, Langendijk PNJ, de Goede PNFC. Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization. Biomed Chromatogr 1989;491:107-116.
16. Cole JO, Kando JC. Adverse behavioral events reported in patients taking alprozolam and other benzodiazepines. J Clin Psychiatry 1993;54 (Suppl. 10):49-61.
17. Short TG, Forrest P, Galletly DC. Paradoxical reactions to benzodiazepines - a genetically determined phenomenon. Anaesth Intens Care 1987;15:330-331.
18. Ritz R. Benzodiazepine sedation in adult ICU patients. Intens Care Med 1991;17:S11-S14.